India · Delayed Price · Currency is INR M. K. Proteins Statistics
Total Valuation
M. K. Proteins has a market cap or net worth of INR 2.06 billion. The enterprise value is 2.04 billion.
| Market Cap | 2.06B |
| Enterprise Value | 2.04B |
Important Dates
The next estimated earnings date is Thursday, January 29, 2026.
| Earnings Date | Jan 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
M. K. Proteins has 375.37 million shares outstanding. The number of shares has decreased by -0.74% in one year.
| Current Share Class | 375.37M |
| Shares Outstanding | 375.37M |
| Shares Change (YoY) | -0.74% |
| Shares Change (QoQ) | -4.36% |
| Owned by Insiders (%) | 61.88% |
| Owned by Institutions (%) | n/a |
| Float | 94.50M |
Valuation Ratios
The trailing PE ratio is 25.00.
| PE Ratio | 25.00 |
| Forward PE | n/a |
| PS Ratio | 0.64 |
| PB Ratio | 2.80 |
| P/TBV Ratio | 2.80 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.81, with an EV/FCF ratio of -13.55.
| EV / Earnings | 24.21 |
| EV / Sales | 0.63 |
| EV / EBITDA | 15.81 |
| EV / EBIT | 16.32 |
| EV / FCF | -13.55 |
Financial Position
The company has a current ratio of 15.24, with a Debt / Equity ratio of 0.03.
| Current Ratio | 15.24 |
| Quick Ratio | 2.22 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.15 |
| Debt / FCF | -0.13 |
| Interest Coverage | 8.28 |
Financial Efficiency
Return on equity (ROE) is 12.13% and return on invested capital (ROIC) is 10.23%.
| Return on Equity (ROE) | 12.13% |
| Return on Assets (ROA) | 10.34% |
| Return on Invested Capital (ROIC) | 10.23% |
| Return on Capital Employed (ROCE) | 16.53% |
| Weighted Average Cost of Capital (WACC) | 2.60% |
| Revenue Per Employee | 64.81M |
| Profits Per Employee | 1.69M |
| Employee Count | 50 |
| Asset Turnover | 4.29 |
| Inventory Turnover | 6.64 |
Taxes
In the past 12 months, M. K. Proteins has paid 30.47 million in taxes.
| Income Tax | 30.47M |
| Effective Tax Rate | 26.55% |
Stock Price Statistics
The stock price has decreased by -27.54% in the last 52 weeks. The beta is -0.39, so M. K. Proteins's price volatility has been lower than the market average.
| Beta (5Y) | -0.39 |
| 52-Week Price Change | -27.54% |
| 50-Day Moving Average | 6.02 |
| 200-Day Moving Average | 6.75 |
| Relative Strength Index (RSI) | 42.73 |
| Average Volume (20 Days) | 245,954 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, M. K. Proteins had revenue of INR 3.24 billion and earned 84.31 million in profits. Earnings per share was 0.22.
| Revenue | 3.24B |
| Gross Profit | 283.41M |
| Operating Income | 125.01M |
| Pretax Income | 114.79M |
| Net Income | 84.31M |
| EBITDA | 128.49M |
| EBIT | 125.01M |
| Earnings Per Share (EPS) | 0.22 |
Balance Sheet
The company has 43.59 million in cash and 19.86 million in debt, with a net cash position of 23.73 million or 0.06 per share.
| Cash & Cash Equivalents | 43.59M |
| Total Debt | 19.86M |
| Net Cash | 23.73M |
| Net Cash Per Share | 0.06 |
| Equity (Book Value) | 737.26M |
| Book Value Per Share | 1.97 |
| Working Capital | 627.24M |
Cash Flow
In the last 12 months, operating cash flow was -127.62 million and capital expenditures -23.04 million, giving a free cash flow of -150.66 million.
| Operating Cash Flow | -127.62M |
| Capital Expenditures | -23.04M |
| Free Cash Flow | -150.66M |
| FCF Per Share | -0.40 |
Margins
Gross margin is 8.75%, with operating and profit margins of 3.86% and 2.60%.
| Gross Margin | 8.75% |
| Operating Margin | 3.86% |
| Pretax Margin | 3.54% |
| Profit Margin | 2.60% |
| EBITDA Margin | 3.97% |
| EBIT Margin | 3.86% |
| FCF Margin | n/a |
Dividends & Yields
M. K. Proteins does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.74% |
| Shareholder Yield | 0.74% |
| Earnings Yield | 4.08% |
| FCF Yield | -7.30% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 15, 2024. It was a forward split with a ratio of 3.
| Last Split Date | Mar 15, 2024 |
| Split Type | Forward |
| Split Ratio | 3 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |